Avalyn Pharma Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -26,708 | |
EBIT | -26,771 | |
Net Income | -26,869 | -17,503 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -30,209 | -19,283 |
Cash | 92,310 | |
Basic Shares | 41,812 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -91,250 | |
EBIT | -91,292 | |
Net Income | -85,204 | -49,744 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -81,828 | -48,463 |
Cash | 52,315 | 23,955 |
Basic Shares | 41,812 | 41,812 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$21.83 |